Recent studies have suggested meaningful relationships between alcohol abuse and dependence, victimization and post-traumatic stress disorder (PTSD). It has been suggested that as many as 30% of alcoholic individuals have been the victims of childhood or adult physical or sexual assault. While PTSD can result from a variety of traumatic events, crime-related events, including childhood sexual and physical assault, are a common cause of PTSD (CR-PTSD) and will be the focus of this proposal. It is likely that untreated CR-PTSD can worsen the course of alcohol use disorders and make it difficult to decrease consumption and attain abstinence. The goal of the proposed study is to investigate the use of a medication, sertraline, which has been shown in preliminary studies to decrease alcohol consumption and to decrease the symptoms of CR-PTSD, in individuals with concurrent CR-PTSD and an alcohol use disorder. The study will be a 12 week placebo-controlled double-blind study with a 1 week placebo wash-out. All subjects will receive 12 sessions of concurrent cognitive behavioral therapy for alcoholism. Subjects will include 122 individuals who meet DSM-IV criteria for alcohol abuse or dependence and current CR-PTSD. Comprehensive evaluation will be done at study entry, treatment termination, 6,9, and 12 months after study entry. Outcome will be evaluated along multiple dimensions.
The specific aims of this proposal are the following: (1) To use state-of-the-art psychological and psychiatric instruments to determine histories of trauma, sequelae of trauma and psychiatric symptoms among individuals presenting for alcohol treatment. (2) To conduct a 12-week double-blind placebo-controlled outpatients clinical trial of sertraline in individuals with concurrent alcoholism and CR-PTSD. (3) To evaluate the efficacy of the experimental treatment over the course of one year as measured by changes in substance use, CR-PTSD symptoms and psychiatric symptoms as well as psychosocial indicators. In summary, this project targets the treatment of individuals with alcohol use disorders who have been victims of violence and have current CR-PTSD. The efficacy of a pharmacologic treatment targeting both decreased alcohol consumption and decreased CR-PTSD symptomatology will be explored. The overall goal of the project is to further explore the relationship between CR-PTSD and alcoholism and to improve treatment outcome for this population.

Agency
National Institute of Health (NIH)
Institute
National Institute on Alcohol Abuse and Alcoholism (NIAAA)
Type
Specialized Center (P50)
Project #
5P50AA010761-03
Application #
6267139
Study Section
Project Start
1997-12-01
Project End
1998-11-30
Budget Start
1997-10-01
Budget End
1998-09-30
Support Year
3
Fiscal Year
1998
Total Cost
Indirect Cost
Name
Medical University of South Carolina
Department
Type
DUNS #
183710748
City
Charleston
State
SC
Country
United States
Zip Code
29425
McGuier, Natalie S; Rinker, Jennifer A; Cannady, Reginald et al. (2018) Identification and validation of midbrain Kcnq4 regulation of heavy alcohol consumption in rodents. Neuropharmacology 138:10-19
Nimitvilai, Sudarat; Lopez, Marcelo F; Woodward, John J (2018) Effects of monoamines on the intrinsic excitability of lateral orbitofrontal cortex neurons in alcohol-dependent and non-dependent female mice. Neuropharmacology 137:1-12
Dowdle, Logan T; Brown, Truman R; George, Mark S et al. (2018) Single pulse TMS to the DLPFC, compared to a matched sham control, induces a direct, causal increase in caudate, cingulate, and thalamic BOLD signal. Brain Stimul 11:789-796
Zamudio-Bulcock, Paula A; Homanics, Gregg E; Woodward, John J (2018) Loss of Ethanol Inhibition of N-Methyl-D-Aspartate Receptor-Mediated Currents and Plasticity of Cerebellar Synapses in Mice Expressing the GluN1(F639A) Subunit. Alcohol Clin Exp Res 42:698-705
Cannady, Reginald; Rinker, Jennifer A; Nimitvilai, Sudarat et al. (2018) Chronic Alcohol, Intrinsic Excitability, and Potassium Channels: Neuroadaptations and Drinking Behavior. Handb Exp Pharmacol 248:311
Harlan, Benjamin A; Becker, Howard C; Woodward, John J et al. (2018) Opposing actions of CRF-R1 and CB1 receptors on VTA-GABAergic plasticity following chronic exposure to ethanol. Neuropsychopharmacology 43:2064-2074
Hanlon, Colleen A; Dowdle, Logan T; Henderson, J Scott (2018) Modulating Neural Circuits with Transcranial Magnetic Stimulation: Implications for Addiction Treatment Development. Pharmacol Rev 70:661-683
Hanlon, Colleen A; Dowdle, Logan T; Gibson, Nicole B et al. (2018) Cortical substrates of cue-reactivity in multiple substance dependent populations: transdiagnostic relevance of the medial prefrontal cortex. Transl Psychiatry 8:186
Gioia, Dominic A; Xu, Minfu; Wayman, Wesley N et al. (2018) Effects of drugs of abuse on channelrhodopsin-2 function. Neuropharmacology 135:316-327
Anton, Raymond F; Latham, Patricia K; Voronin, Konstantin E et al. (2018) Nicotine-Use/Smoking Is Associated with the Efficacy of Naltrexone in the Treatment of Alcohol Dependence. Alcohol Clin Exp Res 42:751-760

Showing the most recent 10 out of 209 publications